William D. Waddill serves as Executive at OncoMed Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, William D. Waddill has executed 43 insider transactions totaling $5.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 3,762 shares valued at $0.
William D. Waddill currently holds 3,762 shares of OncoMed Pharmaceuticals Inc (OMED), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William D. Waddill has been a net seller of OMED stock. They have purchased $0 and sold $5.5M worth of shares.
William D. Waddill's most recent insider trade was on Jan 2, 2026, when they sold 3,762 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 19, 2025 | ARWR | $34.3K | Sale | 500 | $68.53 | Discretionary |
| Dec 19, 2025 | ARWR | $161.1K | Sale | 2,416 | $66.66 | Discretionary |
| Dec 19, 2025 | ARWR | $370.7K | Sale | 5,451 | $68.01 | Discretionary |
| Dec 16, 2025 | ARWR | $0 | Award | 7,819 | $N/A | Discretionary |
| Oct 10, 2025 | PTGX | $277.0K | Sale | 4,000 | $69.25 | Discretionary |
| Oct 10, 2025 | PTGX | $83.8K | Option Exercise | 12,000 | $6.98 | Discretionary |
| Oct 10, 2025 | PTGX | $702.5K | Sale | 8,000 | $87.81 | Discretionary |
| Sep 22, 2025 | PTGX | $257.0K | Sale | 4,000 | $64.25 | Discretionary |
| Aug 27, 2025 | PTGX | $237.0K | Sale | 4,000 | $59.25 | Discretionary |
| Sep 10, 2024 | PTGX | $103.0K | Option Exercise | 8,000 | $12.88 | Planned |
| Sep 10, 2024 | PTGX | $360.0K | Sale | 8,000 | $45.00 | Planned |
| Jul 24, 2024 | PTGX | $103.0K | Option Exercise | 8,000 | $12.88 | Planned |
| Jul 24, 2024 | PTGX | $320.0K | Sale | 8,000 | $40.00 | Planned |
| Jun 7, 2024 | PTGX | $280.0K | Sale | 8,000 | $35.00 | Planned |
| Jun 7, 2024 | PTGX | $103.0K | Option Exercise | 8,000 | $12.88 | Planned |
| Mar 1, 2024 | PTGX | $79.0K | Option Exercise | 12,975 | $6.09 | Planned |
| Mar 1, 2024 | PTGX | $406.6K | Sale | 12,975 | $31.34 | Planned |
| Jan 11, 2024 | ARWR | $99.6K | Sale | 2,634 | $37.81 | Planned |
| Jan 11, 2024 | ARWR | $50.2K | Sale | 1,300 | $38.59 | Planned |
| Dec 15, 2023 | ARWR | $380.8K | Award | 14,987 | $25.41 | Discretionary |
| Jan 10, 2023 | ARWR | $0 | Award | 7,867 | $N/A | Discretionary |
| Jan 9, 2023 | ARWR | $96.0K | Sale | 3,200 | $30.00 | Discretionary |
| May 3, 2022 | PTGX | $103.1K | Option Exercise | 12,000 | $8.59 | Discretionary |
| Jan 7, 2022 | ARWR | $0 | Award | 6,400 | $N/A | Discretionary |
| Jan 3, 2022 | ARWR | $138.3K | Sale | 2,128 | $65.01 | Discretionary |
| Jan 3, 2022 | ARWR | $18.0K | Sale | 272 | $66.25 | Discretionary |
| Jan 3, 2022 | ARWR | $134.9K | Sale | 2,100 | $64.23 | Discretionary |
| Jan 4, 2021 | ARWR | $285.3K | Sale | 3,750 | $76.08 | Discretionary |